A detailed history of Columbia Trust CO 01012016 transactions in Abbott Laboratories stock. As of the latest transaction made, Columbia Trust CO 01012016 holds 5,629 shares of ABT stock, worth $662,871. This represents 0.28% of its overall portfolio holdings.

Number of Shares
5,629
Previous 5,398 4.28%
Holding current value
$662,871
Previous $522,000 18.58%
% of portfolio
0.28%
Previous 0.3%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

BUY
$90.19 - $110.4 $20,833 - $25,502
231 Added 4.28%
5,629 $619,000
Q3 2023

Oct 16, 2023

BUY
$95.53 - $114.62 $32,766 - $39,314
343 Added 6.79%
5,398 $522,000
Q2 2023

Jul 18, 2023

SELL
$100.78 - $112.29 $3,628 - $4,042
-36 Reduced 0.71%
5,055 $551,000
Q1 2023

Apr 11, 2023

SELL
$96.86 - $114.01 $95,988 - $112,983
-991 Reduced 16.29%
5,091 $515,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $5,323 - $6,245
56 Added 0.93%
6,082 $667,000
Q3 2022

Oct 11, 2022

BUY
$96.76 - $112.03 $1,548 - $1,792
16 Added 0.27%
6,026 $583,000
Q2 2022

Jul 19, 2022

BUY
$102.07 - $123.37 $1,633 - $1,973
16 Added 0.27%
6,010 $653,000
Q1 2022

Apr 15, 2022

BUY
$114.02 - $139.04 $30,101 - $36,706
264 Added 4.61%
5,994 $705,000
Q3 2021

Oct 14, 2021

BUY
$116.66 - $129.06 $60,196 - $66,594
516 Added 9.9%
5,730 $677,000
Q2 2021

Jul 13, 2021

SELL
$105.79 - $124.53 $31,313 - $36,860
-296 Reduced 5.37%
5,214 $605,000
Q1 2021

Apr 16, 2021

SELL
$108.84 - $128.23 $24,706 - $29,108
-227 Reduced 3.96%
5,510 $659,000
Q4 2020

Jan 21, 2021

SELL
$105.0 - $114.42 $27,720 - $30,206
-264 Reduced 4.4%
5,737 $627,000
Q2 2020

Jul 21, 2020

SELL
$76.57 - $98.0 $16,156 - $20,678
-211 Reduced 3.4%
6,001 $547,000
Q1 2020

May 06, 2020

SELL
$62.82 - $91.86 $8,292 - $12,125
-132 Reduced 2.08%
6,212 $489,000
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $498,067 - $554,465
6,344 New
6,344 $550,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Columbia Trust CO 01012016 Portfolio

Follow Columbia Trust CO 01012016 and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Trust CO 01012016, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Trust CO 01012016 with notifications on news.